MBHB Partner Kevin Noonan Authors BioProcess International Article, “The CRISPR Saga (So Far)”
April 19, 2022
McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D., analyzes the ongoing dispute over the inventorship of CRISPR technology in BioProcess International. View the article.
